Therapeutics: Potassium channel K2p9.1 (KCNK9)

Patient sample, cell culture and mouse studies suggest inhibiting KCNK9 could help treat cancer. In patients with squamous cell lung cancer or breast cancer, low tumor levels of KCNK9 were associated ...